Filing Flows › Aurinia Pharmaceuticals (AUPH) › How it makes money
How Aurinia Pharmaceuticals (AUPH) makes money
Aurinia Pharmaceuticals (AUPH) made $83.7M of revenue in the third quarter 2026 (Q3 2026), +14% from a year earlier. Net product sales brought in $79.4M (95%); License, collaboration and royalty revenue brought in $4.3M (5%). Of every dollar of revenue, 42¢ was left as operating profit, 38¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Net product sales | $79.4M | 94.9% | 0% | +12% |
| License, collaboration and royalty revenue | $4.3M | 5.1% | +12% | +51% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $83.7M | 100.0% |
| Operating profit | $35.4M | 42.3% |
| Income tax | $7.0M | 8.4% |
| Net earnings | $31.7M | 37.9% |
| Operating cash flow | $46.4M | 55.4% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $83.7M | +14% |
| Q2 2026 | $83.2M | +19% |
| Q1 2026 | $77.7M | +24% |
| Q4 2025 | $77.1M | +29% |
| Q3 2025 | $73.5M | +8% |
| Q2 2025 | $70.0M | +22% |
| Q1 2025 | $62.5M | +24% |
From Aurinia Pharmaceuticals' 10-Q filed Oct 30, 2026 (on EDGAR).
Questions
How does Aurinia Pharmaceuticals make money?
Aurinia Pharmaceuticals (AUPH) made $83.7M of revenue in the third quarter 2026 (Q3 2026), +14% from a year earlier. Net product sales brought in $79.4M (95%); License, collaboration and royalty revenue brought in $4.3M (5%). Of every dollar of revenue, 42¢ was left as operating profit, 38¢ was left as net earnings.
What is Aurinia Pharmaceuticals' biggest business?
Net product sales: $79.4M in the third quarter 2026, 95% of revenue, +12% from a year earlier.
What is Aurinia Pharmaceuticals' profit margin?
Net earnings were $31.7M, 37.9% of revenue, in the third quarter 2026; the operating margin was 42.3%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.